CAMPTODACTYLY ACQUIRED

This adverse event was reported 11 times

These drugs are most commonly taken by patients reporting CAMPTODACTYLY ACQUIRED:

# Drug Count
0 ETANERCEPT 3
1 INFLIXIMAB 3
2 METHOTREXATE 3
3 METHOTREXATE SODIUM 3
4 NAPROXEN 2
5 NAPROXEN SODIUM 2
6 ADALIMUMAB 1
7 AZITHROMYCIN DIHYDRATE 1
8 ETHOSUXIMIDE 1
9 FOLIC ACID 1
See all common drugs associated with CAMPTODACTYLY ACQUIRED

CAMPTODACTYLY ACQUIRED is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 TERBUTALINE SULFATE 1 0.0005
1 ETHOSUXIMIDE 1 0.0004
2 HYDROXYZINE PAMOATE 1 0.0003
3 PHYTONADIONE 1 0.0001
4 PHENOBARBITAL 1 0.0001
5 VALPROATE SODIUM 1 0.0000
6 PAROXETINE HYDROCHLORIDE 1 0.0000
7 AZITHROMYCIN DIHYDRATE 1 0.0000
8 NAPROXEN SODIUM 2 0.0000
9 INFLIXIMAB 3 0.0000
See all drugs enriched for association with CAMPTODACTYLY ACQUIRED

CAMPTODACTYLY ACQUIRED is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Vitamin K [EPC] 1 0.0001
1 Anti-epileptic Agent [EPC] 2 0.0000
2 Parathyroid Hormone Analog [EPC] 1 0.0000
3 Folate Analog Metabolic Inhibitor [EPC] 3 0.0000
4 Mood Stabilizer [EPC] 1 0.0000
5 Vitamin D [EPC] 1 0.0000
6 Vitamin B12 [EPC] 1 0.0000
7 Tumor Necrosis Factor Blocker [EPC] 3 0.0000
8 Vitamin C [EPC] 1 0.0000
9 Nonsteroidal Anti-inflammatory Drug [EPC] 2 0.0000
See all drug classes enriched for association with CAMPTODACTYLY ACQUIRED